Cancer Cell Biology

You have full text access to this OnlineOpen article

CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival

  1. Carla Palma†,*,
  2. Monica Binaschi,
  3. Mario Bigioni,
  4. Carlo Alberto Maggi,
  5. Cristina Goso

Article first published online: 28 OCT 2003

DOI: 10.1002/ijc.11574

Issue

International Journal of Cancer

International Journal of Cancer

Volume 108, Issue 3, pages 390–398, 20 January 2004

Additional Information

How to Cite

Palma, C., Binaschi, M., Bigioni, M., Maggi, C. A. and Goso, C. (2004), CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival. Int. J. Cancer, 108: 390–398. doi: 10.1002/ijc.11574

Author Information

  1. Department of Pharmacology, Menarini Ricerche SpA, Rome, Italy

  1. †

    Fax: +39-06-9100220

*Department of Pharmacology, Menarini Ricerche SpA, Via Tito Speri, 10, 00040 Pomezia, Rome, Italy

Publication History

  1. Issue published online: 21 NOV 2003
  2. Article first published online: 28 OCT 2003
  3. Manuscript Accepted: 1 SEP 2003
  4. Manuscript Revised: 16 JUL 2003
  5. Manuscript Received: 2 APR 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (572K)

REFERENCES

  • 1
    Goodwin RG, Din WS, Davis-Smith T, Anderson DM, Gimpel SD, Sato TA, et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol 1993; 23: 2631–41.
    Direct Link:
  • 2
    Pollok KE, Kim Y-J, Zhou, Z, Hurtado J, Kim KK, Pickard RT, Kwon BS. Inducible T cell antigen 4-1BB. J Immunol 1993; 150: 771–81.
  • 3
    Kim YJ, Kim SH, Mantel P, Kwon BS. Human 4-1BB regulates CD28 co-stimulation to promote TH1 cell responses. Eur J Immunol 1998; 28: 881–90.
    Direct Link:
  • 4
    Takahashi C, Mittler RS, Vella AT. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 1999; 162: 5037–40.
  • 5
    Hurtado JC, Kim YJ, Kwon BS. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol 1997; 158: 2600–9.
  • 6
    Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, Hellstrom KE, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 1997; 3: 682–5.
  • 7
    Martinet O, Ermekova V, Qiao JQ, Sauter B, Mandeli J, Chen L, Chen SH. Immunomodulatory gene therapy with interleukin-12 and 4-1BB ligand: long-term remission of liver metastases in a mouse model. J Natl Cancer Inst 2000; 92: 931–6.
  • 8
    Wilcox RA, Flies DB, Zhu G, Johnson AJ, Tamada K, Chapoval AI, et al. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J Clin Invest 2002; 109: 651–9.
  • 9
    Schwarz H, Valbracht J, Tuckwell J, Kempis J, Lotz M. ILA, the human 4-1BB homologue is inducible in lymphoid and other cell lines. Blood 1995; 85: 1043–52.
  • 10
    Heinisch IVWM, Bizer C, Volgger W, Simon H-U. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders. J Allergy Clin Immunol 2001; 108: 21–8.
  • 11
    Wilcox RA, Chapoval AI, Gorski KS, Otsuji M, Shin T, Flies DB, et al. Cutting edge: expression of functional CD137 receptor by dendritic cells. J Immunol 2002; 168: 4262–7.
  • 12
    Heinisch IVWM, Daigle I, Knopfli B, Simon H-U. CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Eur J Immunol 2000; 30: 3441–6.
    Direct Link:
  • 13
    Langstein J, Michel J, Fritsche J, Kreutz M, Andreesen R, Schwarz H. CD137 (ILA/4-1BB), a member of the TNF receptor family regulates monocyte activation via reverse signaling. J Immunol 1998; 160: 2488–94.
  • 14
    Langstein J, Michel J, Schwarz H. CD137 induces proliferation and endomitosis in monocytes. Blood 1999; 94: 3161–8.
  • 15
    Alderson MR, Smith CA, Tough TW, Davis-Smith T, Armitage RJ, Falk B, Roux E, Baker E, Sutherland GR, Din WS, Goodwin RG. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol 1994; 24: 2219–27.
    Direct Link:
  • 16
    Lane PJ, Brocker T. Developmental regulation of dendritic cell function. Curr Opin Immunol 1999; 11: 308–13.
  • 17
    Michel J, Pauly S, Langstein P, Krammer PH, Schwarz H. CD137-induced apoptosis is independent of CD95. Immunology 1999; 98: 42–6.
    Direct Link:
  • 18
    Schwarz H, Blanco F, Valbracht J, Kempis J, Lotz M. ILA, a member of the human NGF/TNF receptor family regulates T lymphocyte proliferation and survival. Blood 1996; 87: 2839–45.
  • 19
    Zhou Z, Kim S, Hurtado J, Lee ZH, Kim KK, Pollok KE, Kwon BS. Characterization of human homologue of 4-1BB and its ligand. Immunol Lett 1995; 45: 67–73.
  • 20
    Garni-Wagner BA, Lee ZH, Kim Y-J, Wilde C, Kang C-Y, Kwon BS. 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans. Cell Immunol 1996; 169: 91–8.
  • 21
    Salih HR, Scmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, et al. Soluble CD137 (4-1BB) Ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J Immunol 2001; 167: 4059–66.
  • 22
    Kebelmann-Betzing C, Korner G, Badiali L, Buchwald D, Moricke A, Korte A, et al. Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor. Cytokine 2001; 7: 39–50.
  • 23
    Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, et al. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res 1997; 57: 4940–7.
  • 24
    Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, et al. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells. J Immunol 2000; 165: 2903–10.
  • 25
    Michel JM, Langstein J, Hofstaedter F, Schwarz H. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur J Immunol 1998; 28: 290–5.
    Direct Link:
  • 26
    Gruss HJ. Molecular, structural and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res 1996; 26: 143–59.
  • 27
    von Kempis J, Schwarz H, Lotz M. Differentiation-dependent and stimulus-specific expression of ILA, the human 4-1BB homologue, in cells of mesenchymal origin. Osteoarthritis Cartilage 1997; 5: 394–406.
  • 28
    Kienzle G, von Kempis J. CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. Int Immunol 2000; 12: 73–82.
  • 29
    Diehl L, van Mierlo GJD, den Boer AT, van der Voort E, Fransen M, van Bostelen L, Krimpenfort P, Melief CJM, Mittler R, Toes REM, Offringa R. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J Immunol 2002; 168: 3755–62.
  • 30
    Kim K-M, Kim HW, Kim J-O, Baek K-M, Kim JG, Kang C-Y. Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes. Immunology 2002; 107: 472–9.
    Direct Link:
  • 31
    Voorzanger-Rousselot N, Favrot M-C, Blay J-Y. Resistance to cytotoxic chemotherapy induced by CD40 Ligand in lymphoma cells. Blood 1998; 92: 3381–7.
  • 32
    Broll K, Richter G, Pauly S, Hofstaedter F, Schwarz H. CD137 expression in tumor vessel walls. Am J Clin Pathol 2001; 115: 543–9.
  • 33
    Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai S-C, Pardee AB. Apoptosis caused by chemotherapeutic inhibition of Nuclear Factor-kB activation. Cancer Res 2003; 63: 290–5.
View Full Article (HTML) Get PDF (572K)